The effect of successful kidney transplantation on ventricular dysfunction and pulmonary hypertension

Transplantation Proceedings

Volumn 42, Issue 9, 2010, Pages 3524-3528

  Casas Aparicio, G ^a   Castillo Martinez L ^a   Orea Tejeda, A ^a   Abasta Jimenez M ^a   Keirns Davies, C ^b   Rebollar Gonzalez V ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVEROLIMUS; LOOP DIURETIC AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; AGE DISTRIBUTION; ARTERIAL WALL THICKNESS; ARTICLE; CHEMICAL PARAMETERS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART STROKE VOLUME; HEART VENTRICLE FUNCTION; HEART VENTRICLE SIZE; HUMAN; HYPERTENSION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUNG ARTERY PRESSURE; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RENAL REPLACEMENT THERAPY; SEX RATIO; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION; TREATMENT OUTCOME;

ADULT; BLOOD PRESSURE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION, PULMONARY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MEXICO; MIDDLE AGED; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 78649476691     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.06.026     Document Type: Article

References (20)

1. H.O. Ventura, and M.R. Mehra Improvement of heart failure after renal transplantation The complex maze of cardio-renal interaction J Am Coll Cardiol 45 2005 1061
2. J.D. Harnett, R.N. Foley, and G.M. Kent Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors Kidney Int 47 1995 884
3. A.G. Stack, and W.E. Bloembergen A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident U.S. dialysis patients Am J Kidney Dis 38 2001 992
4. R.K. Wali, G.S. Wang, and S.S. Gottlieb Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease J Am Coll Cardiol 45 2005 1051
5. C. Rigatto, and P. Parfrey Therapy insight: management of cardiovascular disease in the renal transplant recipient Nat Clin Pract Nephrol 2 2006 456
6. M. Tonelli, C. Bohm, and S. Pandeya Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency Am J Kidney Dis 37 2001 484
7. C. Rigatto, R.N. Foley, and G.M. Kent Long-term changes in left ventricular hypertrophy after renal transplantation Transplantation 70 2000 570
8. National Kidney Foundation K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients Am J Kidney Dis 45 2005 16
9. S.R. Ferreira, V.A. Moiss, A. Tavares, and A. Pacheco-Silva Cardiovascular effects of successful renal transplantation; a one year sequential study of left ventricular morphology and function, and 24 hour blood pressure profile Transplantation 74 2002 1580
10. M. Yigla, F. Nakhoul, and A. Sabag Pulmonary hypertension in patients with end-stage renal disease Chest 123 2003 1577
11. J.M. Arnold, B.M. Massie, and D.W. Baker HFSA 2006 comprehensive HF practice guideline J Card Fail 12 2006 e1
12. P. Carson, B.M. Massie, and R. McKelvie The Irbesartan in Heart Failure with Preserved Systolic Function (I-PRESERVE) trial: rationale and design J Card Fail 11 2005 576
13. J.J. de Lima, M.L. Vieira, and L.F. Viviani Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients Nephrol Dial Transplant 4 2002 645
14. R. Zolty, P.J. Hynes, and T.J. Vittorio Severe left ventricular systolic dysfunction may reverse with renal transplantation: uremic cardiomyopathy and cardiorrenal syndrome Am J Transplant 8 2008 2219
15. W.H. Horl The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes Nephrol Dial Transplant 19 suppl 5 2004 V2
16. P. Pozzoni, M. Pozzi, L. del Vecchio, and F. Locatelli Epidemiology and prevention of cardiovascular complication in chronic kidney disease patients Semin Nephrol 24 2004 417
17. J. Hung, P.J. Harris, and R.F. Uren Uremic cardiomyopathyeffect of hemodialysis on left ventricular function in endstage renal failure N Engl J Med 302 1980 547
18. Q. Yao, J. Axelsson, and O. Heimburger Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences Minerva Urol Nefrol 56 2004 237
19. M. Nagashima, K. Hashimoto, and T. Shinsato Marked improvement of left ventricular function after parathyroidectomy in a hemodialysis patient with secondary hyperparathyroidism and left ventricular dysfunction 67 2003 269
20. M. Mahdavi-Mazdeh, S. Alijavad-Mousavi, and H. Yahyazadeh Pulmonary hypertension in hemodialysis patientes Saudi J Kidney Dis Transpl 19 2008 189